#GNMX #NBRV #TGTX should investors buy these 3 beat down biotech?


17-Oct-2017 21:47 PM



  1. #GNMX Aevi Genomics Medicine, Inc


    2. #NBRV Nabriva Therapeutics PLC

  • Still positive on YTD performance +11.74%
  • Investors were disappointed on the big raised secondary after success Phase 3.
  • Stock took a beating, see chart for support levels


    3.  #TGTX  TG Therapeutics Inc

Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.